Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Unichem Laboratories Ltd.

BSE: 506690 | NSE: UNICHEMLAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE351A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Apr 20, 16:01
345.00 -5.85 (-1.67%)
Volume
AVERAGE VOLUME
5-Day
3,582
10-Day
2,444
30-Day
7,191
310
  • Prev. Close

    350.85

  • Open Price

    356.45

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Apr 20, 15:47
345.45 -5.75 (-1.64%)
Volume
AVERAGE VOLUME
5-Day
48,988
10-Day
44,506
30-Day
49,268
12,339
  • Prev. Close

    351.20

  • Open Price

    351.20

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Unichem Laboratories (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,688.80 1,392.62 1,030.51 919.18 1,078.52  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 1,688.80 1,392.62 1,030.51 919.18 1,078.52  
Total Operating Revenues 1,735.70 1,442.17 1,072.43 942.93 1,123.97  
Other Income 40.83 30.39 41.85 42.07 47.37  
Total Revenue 1,776.53 1,472.55 1,114.28 984.99 1,171.34  
EXPENSES  
Cost Of Materials Consumed 829.77 716.92 500.34 434.92 449.14  
Purchase Of Stock-In Trade 0.85 0.91 1.53 1.35 0.54  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -33.33 -26.36 22.01 -52.79 -16.73  
Employee Benefit Expenses 287.51 283.14 270.86 250.79 234.04  
Finance Costs 7.62 10.42 9.38 2.07 1.30  
Depreciation And Amortisation Expenses 108.41 105.46 105.98 83.19 75.89  
Other Expenses 397.02 416.63 367.19 344.15 361.52  
Total Expenses 1,597.85 1,507.13 1,280.71 1,071.74 1,105.70  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 178.68 -34.57 -166.43 -86.75 65.65  
Exceptional Items 4.00 -57.61 -112.66 0.00 0.00  
Profit/Loss Before Tax 182.68 -92.18 -279.09 -86.75 65.65  
Tax Expenses-Continued Operations  
Current Tax 0.00 0.00 0.00 0.00 0.00  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 19.72 0.00 20.61 -31.56 10.94  
Tax For Earlier Years 0.00 0.00 0.00 0.24 0.62  
Total Tax Expenses 19.72 0.00 20.61 -31.32 11.56  
Profit/Loss After Tax And Before ExtraOrdinary Items 162.96 -92.18 -299.70 -55.43 54.08  
Profit/Loss From Continuing Operations 162.96 -92.18 -299.70 -55.43 54.08  
Profit/Loss For The Period 162.96 -92.18 -299.70 -55.43 54.08  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 23.15 -13.09 -42.57 -7.87 7.68  
Diluted EPS (Rs.) 23.08 -13.09 -42.57 -7.87 7.68  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 0.00 28.16 28.16  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 0.00 0.00 0.00 200.00 200.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347